ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,678Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 1479

$437K Total Retail Price of All Prescriptions

Rank: 69 out of 1479

580 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,100 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 773 453 1 1
OMEPRAZOLE 543 278 2 7
GABAPENTIN 445 283 3 5
METFORMIN HCL 437 239 4 2
AMLODIPINE BESYLATE 430 299 5 6
RANITIDINE HCL 350 216 6 4
ENALAPRIL MALEATE 299 187 7 3
SYNTHROID 291 194 8 12
ZOLPIDEM TARTRATE 287 132 9 23
LOSARTAN POTASSIUM 280 169 10 8
LISINOPRIL 231 136 11 16
TRAMADOL HCL-ACETAMINOPHEN 219 127 12 18
LEVOTHYROXINE SODIUM 200 73 13 9
AZITHROMYCIN 195 98 14 25
TRAMADOL HCL 190 71 15 20
ATENOLOL 187 92 16 11
METOPROLOL TARTRATE 178 133 17 17
GLIPIZIDE 159 71 18 13
PANTOPRAZOLE SODIUM 155 62 19 48
DICLOFENAC SODIUM 150 62 20 68
SERTRALINE HCL 140 82 21 38
HYDROCHLOROTHIAZIDE 134 80 22 10
AMLODIPINE BESYLATE-BENAZEPRIL 124 72 23 54
LOSARTAN-HYDROCHLOROTHIAZIDE 123 84 24 14
FENOFIBRATE 122 35 25 37
FUROSEMIDE 120 90 26 15
CLOTRIMAZOLE-BETAMETHASONE 104 36 27 39
DICLOFENAC POTASSIUM 101 62 28 29
NABUMETONE 99 24 29 22
FLUTICASONE PROPIONATE 89 40 30 64
ORPHENADRINE CITRATE 84 13 R 31 118
CIPROFLOXACIN HCL 81 34 32 26
LANSOPRAZOLE 78 40 33 92
ALENDRONATE SODIUM 76 58 34 19
DONEPEZIL HCL 75 70 35 45
GLIMEPIRIDE 75 42 35 21
INSULIN SYRINGE 72 46 37 30
PENTOXIFYLLINE 70 58 38 40
NAMENDA 66 66 39 69
DESONIDE 64 41 40 211
RAMIPRIL 63 44 41 63
AMITRIPTYLINE HCL 60 22 R 42 106
KETOCONAZOLE 59 26 43 93
IRBESARTAN 59 43 43 78
METOPROLOL SUCCINATE 58 43 45 51
CRESTOR 58 53 45 73
ISOSORBIDE MONONITRATE ER 58 50 45 31
TRILIPIX 57 28 48 166
CARVEDILOL 57 46 48 32
VERAPAMIL ER 57 55 48 34
CLONIDINE HCL 54 34 51 71
LANTUS 54 41 51 35
QVAR 53 21 53 174
MECLIZINE HCL 53 44 53 50
DIOVAN 51 14 55 85
CAPTOPRIL 51 18 55 28
NAPROXEN SODIUM 51 27 55 87
LYRICA 50 22 58 99
OXYCODONE-ACETAMINOPHEN 50 14 S2 58 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.